BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38444963)

  • 1. Synthesis, biological activities, and evaluation molecular docking-dynamics studies of new phenylisoxazole quinoxalin-2-amine hybrids as potential α-amylase and α-glucosidase inhibitors.
    Mohd Radzuan SN; Phongphane L; Abu Bakar MH; Che Omar MT; Nor Shahril NS; Supratman U; Harneti D; Wahab HA; Azmi MN
    RSC Adv; 2024 Feb; 14(11):7684-7698. PubMed ID: 38444963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation, and molecular modelling of novel quinoxaline-isoxazole hybrid as anti-hyperglycemic.
    Phongphane L; Mohd Radzuan SN; Abu Bakar MH; Che Omar MT; Supratman U; Harneti D; A Wahab H; Azmi MN
    Comput Biol Chem; 2023 Oct; 106():107938. PubMed ID: 37542847
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zheng PF; Xiong Z; Liao CY; Zhang X; Feng M; Wu XZ; Lin J; Lei LS; Zhang YC; Wang SH; Xu XT
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1938-1951. PubMed ID: 34459690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and synthesis of 2-amino-4,6-diarylpyrimidine derivatives as potent α-glucosidase and α-amylase inhibitors: structure-activity relationship,
    Mughal EU; Amjid S; Sadiq A; Naeem N; Nazir Y; Alrafai HA; Hassan AA; Al-Nami SY; Abdel Hafez AA; Ali Shah SW; Ghias M
    J Biomol Struct Dyn; 2024; 42(1):244-260. PubMed ID: 37096830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis,
    Bukhari A; Nadeem H; Imran M; Muhammad SA
    Iran J Basic Med Sci; 2021 Dec; 24(12):1632-1642. PubMed ID: 35432813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of dual-target isoxazolidine-isatin hybrids with antidiabetic potential: Design, synthesis,
    Ghannay S; Aldhafeeri BS; Ahmad I; E A E Albadri A; Patel H; Kadri A; Aouadi K
    Heliyon; 2024 Feb; 10(4):e25911. PubMed ID: 38380049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel C-2 Symmetric Molecules as α-Glucosidase and α-Amylase Inhibitors: Design, Synthesis, Kinetic Evaluation, Molecular Docking and Pharmacokinetics.
    Shahzad D; Saeed A; Larik FA; Channar PA; Abbas Q; Alajmi MF; Arshad MI; Erben MF; Hassan M; Raza H; Seo SY; El-Seedi HR
    Molecules; 2019 Apr; 24(8):. PubMed ID: 30999646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of new anti-diabetic potential agents based on paracetamol incorporating sulfa-drugs: Design, synthesis, α-amylase, and α-glucosidase inhibitors with molecular docking simulation.
    Khamees Thabet H; Ragab A; Imran M; Helal MH; Ibrahim Alaqel S; Alshehri A; Ash Mohd A; Rakan Alshammari M; S Abusaif M; A Ammar Y
    Eur J Med Chem; 2024 Jun; 275():116589. PubMed ID: 38878516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Cyclic Sulfonamides with an
    Saddique FA; Ahmad M; Ashfaq UA; Muddassar M; Sultan S; Zaki MEA
    Pharmaceuticals (Basel); 2022 Jan; 15(1):. PubMed ID: 35056163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and bioactivities evaluation of oleanolic acid oxime ester derivatives as
    Deng XY; Ke JJ; Zheng YY; Li DL; Zhang K; Zheng X; Wu JY; Xiong Z; Wu PP; Xu XT
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):451-461. PubMed ID: 35012401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring chalcone-sulfonyl piperazine hybrids as anti-diabetes candidates: design, synthesis, biological evaluation, and molecular docking study.
    Hosseini Nasab N; Raza H; Eom YS; Shah FH; Kwak JH; Kim SJ
    Mol Divers; 2024 May; ():. PubMed ID: 38775996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of isobenzofuranone derivatives as promising antidiabetic agents: Synthesis, in vitro and in vivo inhibition of α-glucosidase and α-amylase, computational docking analysis and molecular dynamics simulations.
    Zahra S; Zaib S; Khan I
    Int J Biol Macromol; 2024 Feb; 259(Pt 2):129241. PubMed ID: 38199537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antidiabetic Potential of Novel 1,3,5-Trisubstituted-2-Thioxoimidazloidin-4-One Analogues: Insights into α-Glucosidase, α-Amylase, and Antioxidant Activities.
    Khirallah SM; Ramadan HMM; Aladl HAA; Ayaz NO; Kurdi LAF; Jaremko M; Alshawwa SZ; Saied EM
    Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36559028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3,5-Disubstituted-thiazolidine-2,4-dione hybrids as antidiabetic agents: Design, synthesis, in-vitro and In vivo evaluation.
    Singh G; Singh R; Monga V; Mehan S
    Eur J Med Chem; 2024 Feb; 266():116139. PubMed ID: 38252989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of α-glucosidase and α-amylase inhibitory effects of phenoxy chalcones and molecular modeling studies.
    Kurşun-Aktar BS; Adem Ş; Tatar-Yilmaz G; Hameed ZAH; Oruç-Emre EE
    J Mol Recognit; 2023 Nov; 36(11):e3061. PubMed ID: 37720970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, Molecular Docking, and Bioactivity Study of Novel Hybrid Benzimidazole Urea Derivatives: A Promising α-Amylase and α-Glucosidase Inhibitor Candidate with Antioxidant Activity.
    Aroua LM; Alosaimi AH; Alminderej FM; Messaoudi S; Mohammed HA; Almahmoud SA; Chigurupati S; Albadri AEAE; Mekni NH
    Pharmaceutics; 2023 Jan; 15(2):. PubMed ID: 36839780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hydrazinyl thiazole linked indenoquinoxaline hybrids: Potential leads to treat hyperglycemia and oxidative stress; Multistep synthesis, α-amylase, α-glucosidase inhibitory and antioxidant activities.
    Hameed S; Khan KM; Salar U; Özil M; Baltaş N; Saleem F; Qureshi U; Taha M; Ul-Haq Z
    Int J Biol Macromol; 2022 Nov; 221():1294-1312. PubMed ID: 36113601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
    Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
    J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches.
    Mahnashi MH; Alqahtani YS; Alqarni AO; Alyami BA; Jan MS; Ayaz M; Ullah F; Rashid U; Sadiq A
    BMC Complement Med Ther; 2021 Oct; 21(1):270. PubMed ID: 34706708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel pyrazoline linked acyl thiourea pharmacophores as antimicrobial, urease, amylase and α-glucosidase inhibitors: design, synthesis, SAR and molecular docking studies.
    Saeed A; Ahmed A; Haider MB; Ismail H; Hayat K; Shabir G; El-Seedi HR
    RSC Adv; 2024 Jan; 14(2):1018-1033. PubMed ID: 38174269
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.